Acro Biomedical Co., Ltd

(OTCQB:ACBM)

Latest On Acro Biomedical Co., Ltd (ACBM):

Date/Time Type Description Signal Details
2020-12-04 06:27 ESTFinancialsCompany financials have been released.Neutral
2020-11-27 00:48 ESTFinancialsCompany financials have been released.Neutral
2020-11-19 07:52 ESTFinancialsCompany financials have been released.Neutral
2020-10-08 21:10 ESTFinancialsCompany financials have been released.Neutral
2020-10-04 15:26 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 16:39 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 09:19 ESTFinancialsCompany financials have been released.Neutral
2020-08-21 07:13 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 12:45 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 16:27 ESTFinancialsCompany financials have been released.Neutral
2020-08-04 19:44 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 12:07 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 04:35 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 20:44 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 08:32 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 00:50 ESTFinancialsCompany financials have been released.Neutral
2020-07-28 16:08 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 16:25 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 21:15 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 12:36 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 07:35 ESTFinancialsCompany financials have been released.Neutral
2020-07-02 23:38 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 20:15 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 04:06 ESTFinancialsCompany financials have been released.Neutral
2020-06-25 07:28 ESTFinancialsCompany financials have been released.Neutral
2020-06-19 16:05 ESTFinancialsCompany financials have been released.Neutral
2020-06-14 08:16 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 09:50 ESTFinancialsCompany financials have been released.Neutral
2020-06-07 19:51 ESTFinancialsCompany financials have been released.Neutral
2020-06-05 15:37 ESTFinancialsCompany financials have been released.Neutral
2020-06-03 19:28 ESTFinancialsCompany financials have been released.Neutral
2020-05-27 08:54 ESTFinancialsCompany financials have been released.Neutral
2020-05-22 19:19 ESTFinancialsCompany financials have been released.Neutral
2020-05-21 04:41 ESTFinancialsCompany financials have been released.Neutral
2020-05-14 03:56 ESTFinancialsCompany financials have been released.Neutral
2020-05-07 11:39 ESTFinancialsCompany financials have been released.Neutral
2020-05-07 03:58 ESTFinancialsCompany financials have been released.Neutral
2020-05-06 09:19 ESTFinancialsCompany financials have been released.Neutral
2020-05-02 23:46 ESTFinancialsCompany financials have been released.Neutral
2020-05-01 20:04 ESTFinancialsCompany financials have been released.Neutral
2020-04-30 07:33 ESTFinancialsCompany financials have been released.Neutral

About Acro Biomedical Co., Ltd (ACBM):

Acro Biomedical Co., Ltd. develops and markets nutritional products. It sells cordycepin and cordyceps powder, a fungus used in traditional Chinese medicine; and metallothionein MT-3 elizer, a protein powder used in health supplements. The company was formerly known as Killer Waves Hawaii, Inc. and changed its name to Acro Biomedical Co., Ltd. in January 2017. Acro Biomedical Co., Ltd. was founded in 2014 and is based in Fishers, Indiana.

ACBM Quotes by TradingView

See Advanced Chart

General

  • Name Acro Biomedical Co., Ltd
  • Symbol ACBM
  • Type Common Stock
  • Exchange OTCQB
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Fiscal Year EndDecember
  • Web URLhttp://acrobiomedicalco.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 105.82
  • Price/Book (Most Recent Quarter) 192.2
  • Enterprise Value Revenue 105.84
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Profit Margin -4%
  • Return on Assets -22%
  • Revenue 1.46 million
  • Revenue Per Share $0.03
  • Gross Profit 48384
  • Quarterly Earnings Growth -100%
View More

Highlights

  • Market Capitalization 155.22 million
  • Book Value Per Share $0.02
View More

Share Statistics

  • Shares Outstanding 47.76 million
  • Shares Float 17.76 million
  • % Held by Insiders 6281%
View More

Technicals

  • Beta 0.81
  • 52 Week High $5.8
  • 52 Week Low $1.75
  • 50 Day Moving Average 3.02
  • 200 Day Moving Average 3.15
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Acro Biomedical Co., Ltd (ACBM) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Acro Biomedical Co., Ltd (ACBM) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-09-30$N/A$-0.00
2020-06-302020-09-30$N/A$-0.00
2020-03-312020-06-30$687964$-0.00
2019-12-312020-03-31$193536$0.00
2019-09-302019-09-30$N/A$-0.00
2019-06-302019-09-30$N/A$-0.00
2019-03-312019-06-30$N/A$-0.00
2018-12-312019-03-31$1.35 million$-0.00
2018-09-302018-09-30$2.41 million$0.00
2018-06-302018-09-30$2.2 million$0.00
2018-03-312018-06-30$1.96 million$0.00$0.00
2017-12-312018-03-31$1.45 million$0.00$0.00
2017-09-302017-12-31$510000$0.00$0.00
2017-06-302017-09-30$N/A$0.00$0.00
2017-03-312017-06-30$N/A$-0.00$0.00
2016-12-312017-03-31$-0.00$0.00
2016-09-302016-12-31$-0.00$0.00
2016-06-302016-09-30$-0.00$0.00
2016-03-312016-06-30$-0.00$0.00
2015-12-312016-03-31$-0.00$0.00
2015-09-302015-12-31$-0.00$0.00
2015-06-302015-09-30$0.00$0.00
2014-09-302014-12-31$-0.00$0.00

Acro Biomedical Co., Ltd (ACBM) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Acro Biomedical Co., Ltd (ACBM) Chart:

ACBM chart by TradingView

Acro Biomedical Co., Ltd (ACBM) News:

Below you will find a list of latest news for Acro Biomedical Co., Ltd (ACBM) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Acro Biomedical Co., Ltd (ACBM) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Acro Biomedical Co., Ltd (ACBM) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-05-1910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1622996/000164033420001279/0001640334-20-001279-index.htm
2017-01-17UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1622996/000000000017001560/0000000000-17-001560-index.htm
2016-02-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1622996/000164033416000741/0001640334-16-000741-index.htm
2016-03-02424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1622996/000164033416000761/0001640334-16-000761-index.htm
2016-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1622996/000164033416001061/0001640334-16-001061-index.htm
2016-08-0310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1622996/000164033416001481/0001640334-16-001481-index.htm
2016-12-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1622996/000164033416002238/0001640334-16-002238-index.htm
2016-12-21POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1622996/000164033416002273/0001640334-16-002273-index.htm
2017-01-17POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1622996/000164033417000098/0001640334-17-000098-index.htm
2017-01-26CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1622996/000164033417000177/0001640334-17-000177-index.htm
2017-02-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622996/000164033417000223/0001640334-17-000223-index.htm
2017-02-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1622996/000164033417000299/0001640334-17-000299-index.htm
2017-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622996/000164033417000937/0001640334-17-000937-index.htm
2017-05-16NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1622996/000164033417000987/0001640334-17-000987-index.htm
2017-05-2210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1622996/000164033417001056/0001640334-17-001056-index.htm
2017-08-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1622996/000164033417001625/0001640334-17-001625-index.htm
2017-12-29NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405https://www.sec.gov/Archives/edgar/data/1622996/000164033417002745/0001640334-17-002745-index.htm
2018-01-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1622996/000164033418000094/0001640334-18-000094-index.htm
2018-01-1610-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1622996/000164033418000103/0001640334-18-000103-index.htm
2018-02-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1622996/000164033418000321/0001640334-18-000321-index.htm
2018-02-15S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1622996/000164033418000339/0001640334-18-000339-index.htm
2018-03-16S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1622996/000164033418000466/0001640334-18-000466-index.htm
2018-05-16NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1622996/000164033418001018/0001640334-18-001018-index.htm
2018-06-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622996/000164033418001249/0001640334-18-001249-index.htm
2018-07-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622996/000164033418001322/0001640334-18-001322-index.htm
2018-08-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1622996/000164033418001489/0001640334-18-001489-index.htm
2018-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1622996/000164033418001572/0001640334-18-001572-index.htm
2018-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622996/000164033418001967/0001640334-18-001967-index.htm
2018-12-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1622996/000164033418002423/0001640334-18-002423-index.htm
2019-02-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1622996/000164033419000261/0001640334-19-000261-index.htm
2019-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1622996/000164033419000877/0001640334-19-000877-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1622996/000164033419001630/0001640334-19-001630-index.htm
2019-12-31NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405https://www.sec.gov/Archives/edgar/data/1622996/000164033419002689/0001640334-19-002689-index.htm
2020-01-0710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1622996/000164033420000007/0001640334-20-000007-index.htm
2020-01-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622996/000164033420000108/0001640334-20-000108-index.htm
2020-03-2710-KTTransition reports [Rule 13a-10 or 15d-10]https://www.sec.gov/Archives/edgar/data/1622996/000164033420000639/0001640334-20-000639-index.htm
2020-05-18NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1622996/000164033420001257/0001640334-20-001257-index.htm
2020-05-1910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1622996/000164033420001279/0001640334-20-001279-index.htm
2020-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1622996/000164033420002068/0001640334-20-002068-index.htm
2020-08-14NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1622996/000164033420002106/0001640334-20-002106-index.htm
2020-08-1910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1622996/000164033420002198/0001640334-20-002198-index.htm
2020-09-0810-12GRegistration of securities [Section 12(g)]https://www.sec.gov/Archives/edgar/data/1622996/000164033420002297/0001640334-20-002297-index.htm
2016-02-29EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1622996/999999999516003856/9999999995-16-003856-index.htm
2017-01-30EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1622996/999999999517000232/9999999995-17-000232-index.htm
2018-03-19EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1622996/999999999518000630/9999999995-18-000630-index.htm